Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12579166rdf:typepubmed:Citationlld:pubmed
pubmed-article:12579166lifeskim:mentionsumls-concept:C0012634lld:lifeskim
pubmed-article:12579166lifeskim:mentionsumls-concept:C0023434lld:lifeskim
pubmed-article:12579166lifeskim:mentionsumls-concept:C1299003lld:lifeskim
pubmed-article:12579166lifeskim:mentionsumls-concept:C0033105lld:lifeskim
pubmed-article:12579166pubmed:issue1lld:pubmed
pubmed-article:12579166pubmed:dateCreated2003-2-11lld:pubmed
pubmed-article:12579166pubmed:abstractTextPrevious surveys of ocular disease in leukaemia patients have shown the retina, choroid, and orbit as the most commonly involved sites. Depending on the type of leukaemia and the study design, the prevalence of ocular disease in leukaemia varies from 30 to 90%. Although chronic lymphocytic leukaemia (CLL) is the most common leukaemia in Western countries, the prevalence of ocular disease in CLL is not known. The aim of this prospective study was to estimate the prevalence of ocular disease in CLL.lld:pubmed
pubmed-article:12579166pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12579166pubmed:languageenglld:pubmed
pubmed-article:12579166pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12579166pubmed:citationSubsetIMlld:pubmed
pubmed-article:12579166pubmed:statusMEDLINElld:pubmed
pubmed-article:12579166pubmed:monthJanlld:pubmed
pubmed-article:12579166pubmed:issn0950-222Xlld:pubmed
pubmed-article:12579166pubmed:authorpubmed-author:BuchanJJlld:pubmed
pubmed-article:12579166pubmed:authorpubmed-author:BurtonTTlld:pubmed
pubmed-article:12579166pubmed:authorpubmed-author:McKibbinMMlld:pubmed
pubmed-article:12579166pubmed:issnTypePrintlld:pubmed
pubmed-article:12579166pubmed:volume17lld:pubmed
pubmed-article:12579166pubmed:ownerNLMlld:pubmed
pubmed-article:12579166pubmed:authorsCompleteYlld:pubmed
pubmed-article:12579166pubmed:pagination27-30lld:pubmed
pubmed-article:12579166pubmed:dateRevised2009-11-3lld:pubmed
pubmed-article:12579166pubmed:meshHeadingpubmed-meshheading:12579166...lld:pubmed
pubmed-article:12579166pubmed:meshHeadingpubmed-meshheading:12579166...lld:pubmed
pubmed-article:12579166pubmed:meshHeadingpubmed-meshheading:12579166...lld:pubmed
pubmed-article:12579166pubmed:meshHeadingpubmed-meshheading:12579166...lld:pubmed
pubmed-article:12579166pubmed:meshHeadingpubmed-meshheading:12579166...lld:pubmed
pubmed-article:12579166pubmed:meshHeadingpubmed-meshheading:12579166...lld:pubmed
pubmed-article:12579166pubmed:meshHeadingpubmed-meshheading:12579166...lld:pubmed
pubmed-article:12579166pubmed:meshHeadingpubmed-meshheading:12579166...lld:pubmed
pubmed-article:12579166pubmed:meshHeadingpubmed-meshheading:12579166...lld:pubmed
pubmed-article:12579166pubmed:meshHeadingpubmed-meshheading:12579166...lld:pubmed
pubmed-article:12579166pubmed:meshHeadingpubmed-meshheading:12579166...lld:pubmed
pubmed-article:12579166pubmed:meshHeadingpubmed-meshheading:12579166...lld:pubmed
pubmed-article:12579166pubmed:year2003lld:pubmed
pubmed-article:12579166pubmed:articleTitleThe prevalence of ocular disease in chronic lymphocytic leukaemia.lld:pubmed
pubmed-article:12579166pubmed:affiliationDepartment of Ophthamology, St James University Hospital, Leeds, UK.lld:pubmed
pubmed-article:12579166pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12579166pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12579166lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12579166lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12579166lld:pubmed